Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives.

Autor:	Kaye AD; Department of Anesthesiology, LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA 71103, USA. Electronic address: akaye@lsuhsc.edu., Okeagu CN; Department of Anesthesiology, LSUHSC New Orleans, 1542 Tulane Avenue, New Orleans, LA 70112, USA. Electronic address: cokeag@lsuhsc.edu., Pham AD; Department of Anesthesiology, LSUHSC New Orleans, 1542 Tulane Ave, Room 659, New Orleans, LA 70112, USA. Electronic address: apham5@lsuhsc.edu., Silva RA; LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA 71103, USA. Electronic address: rsilv3@lsuhsc.edu., Hurley JJ; Department of Anesthesiology, LSUHSC New Orleans, 433 Bolivar St., New Orleans, LA 70112, USA. Electronic address: jhurle@lsuhsc.edu., Arron BL; Department of Anesthesiology, LSUHSC New Orleans, 1452 Tulane Ave, Suite 659, New Orleans, LA 70112, USA. Electronic address: barron@lsuhsc.edu., Sarfraz N; Department of Psychiatry and Behavioral Medicine, LSU Health Shreveport, Shreveport, LA, USA. Electronic address: sarfraz.noeen@gmail.com., Lee HN; Department of Anesthesiology, LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA 71103, USA. Electronic address: hle6@lsuhsc.edu., Ghali GE; Department of Oral & Maxillofacial Surgery, Craniofacial Surgery/Head & Neck Surgery, LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA 71103, USA. Electronic address: gghali@lsuhsc.edu., Gamble JW; Department of Oral & Maxillofacial Surgery, Craniofacial Surgery/Head & Neck Surgery, LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA 71103, USA., Liu H; Department of Anesthesiology, Milton S. Hershey Medical Center, Penn State University School of Medicine, 500 University Drive, H187, Hershey, PA 17033, USA., Urman RD; Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA. Electronic address: rurman@bwh.harvard.edu., Cornett EM; Department of Anesthesiology, LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA 71103, USA. Electronic address: ecorne@lsuhsc.edu.
Jazyk:	angličtina
Zdroj:	Best practice & research. Clinical anaesthesiology [Best Pract Res Clin Anaesthesiol] 2021 Oct; Vol. 35 (3), pp. 293-306. Date of Electronic Publication: 2020 Nov 17.
DOI:	10.1016/j.bpa.2020.11.009
Abstrakt:	International hospitals and healthcare facilities are facing catastrophic financial challenges related to the COVID-19 pandemic. The American Hospital Association estimates a financial impact of $202.6 billion in lost revenue for America's hospitals and healthcare systems, or an average of $50.7 billion per month. Furthermore, it could cost low- and middle-income countries ~ US$52 billion (equivalent to US$8.60 per person) each four weeks to provide an effective healthcare response to COVID-19. In the setting of the largest daily COVID-19 new cases in the US, this burden will influence patient care, surgeries, and surgical outcomes. From a global economic standpoint, The World Bank projects that global growth is projected to shrink by almost 8% with poorer countries feeling most of the impact, and the United Nations projects that it will cost the global economy around 2 trillion dollars this year. Overall, a lack of preparedness was a major contributor to the struggles experienced by healthcare facilities around the world. Items such as personal protective equipment (PPE) for healthcare workers, hospital equipment, sanitizing supplies, toilet paper, and water were in short supply. These deficiencies were exposed by COVID-19 and have prompted healthcare organizations around the world to invent new essential plans for pandemic preparedness. In this paper, we will discuss the economic impact of COVID-19 on US and international hospitals, healthcare facilities, surgery, and surgical outcomes. In the future, the US and countries around the world will benefit from preparing a plan of action to use as a guide in the event of a disaster or pandemic. Competing Interests: Declaration of competing interest Richard D. Urman received fees or funding from Merck, Medtronic, Takeda, Heron, Sandoz, Acacia, AcelRx. Other authors report no conflicts of interest. (Published by Elsevier Ltd.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu